UBS Group’s Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share CLBR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,687
Closed -$2.15K 10308
2025
Q1
$2.15K Buy
2,687
+1,861
+225% +$1.68K ﹤0.01% 9384
2024
Q4
$1.32K Buy
826
+793
+2,403% +$646 ﹤0.01% 9263
2024
Q3
$11 Buy
+33
New +$11 ﹤0.01% 9349

Other funds holding CLBR.WS

UBS Group's CLBR.WS Position: Q2 2025 in Review

UBS Group sold out of Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (CLBR.WS) in Q2 2025, closing a stake of 2,687 shares — an estimated $2.15K sold.

UBS Group first reported a position in CLBR.WS in Q3 2024 and held it in 3 quarters. The position peaked at $2.15K in Q1 2025. 15 funds tracked by Wall St. Rank hold CLBR.WS as of Q2 2025.

  • UBS Group reported no remaining Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 2,687 Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q2 2025, an estimated $2.15K.
  • UBS Group first reported a position in Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q3 2024 and held it in 3 quarters.
  • UBS Group's Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $2.15K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.